,93 Pan-cancer analysis revealed aberrant CASC5 expression in papillary renal cell carcinoma, lung adenocarcinoma, pancreatic adenocarcinoma, thymoma and urinary bladder cancer. This evidence concerns the gene KNL1 and lung adenocarcinoma.